Menu
Back to User profile » Dr Masaomi Iyo
Papers published by Dr Masaomi Iyo:
Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
Iyo M, Ishigooka J, Nakamura M, Sakaguchi R, Okamoto K, Mao Y, Tsai J, Fitzgerald A, Takai K, Higuchi T
Neuropsychiatric Disease and Treatment 2021, 17:2683-2695
Published Date: 16 August 2021
The Effect of Grandmothers’ Presence on the Provision of Multidisciplinary Perinatal Support for Pregnant and Postpartum Women with Psychosocial Problems
Ogawa M, Hashimoto T, Tanaka M, Tachibana M, Seki R, Sato A, Okayama J, Endo M, Saito N, Sato Y, Watanabe H, Nakazato M, Mori E, Shozu M, Iyo M
Journal of Multidisciplinary Healthcare 2019, 12:1033-1041
Published Date: 11 December 2019
Hospital-based child protection teams that care for parents who abuse or neglect their children recognize the need for multidisciplinary collaborative practice involving perinatal care and mental health professionals: a questionnaire survey conducted in Japan
Okato A, Hashimoto T, Tanaka M, Tachibana M, Machizawa A, Okayama J, Endo M, Senda M, Saito N, Iyo M
Journal of Multidisciplinary Healthcare 2018, 11:121-130
Published Date: 22 February 2018
Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study
Okuda T, Asano K, Numata N, Hirano Y, Yamamoto T, Tanaka M, Matsuzawa D, Shimizu E, Iyo M, Nakazato M
Neuropsychiatric Disease and Treatment 2017, 13:2185-2191
Published Date: 16 August 2017
Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
Hashimoto T, Sakurai D, Oda Y, Hasegawa T, Kanahara N, Sasaki T, Komatsu H, Takahashi J, Oiwa T, Sekine Y, Watanabe H, Iyo M
Neuropsychiatric Disease and Treatment 2015, 11:3031-3040
Published Date: 10 December 2015
Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
Oda Y, Kanahara N, Kimura H, Watanabe H, Hashimoto K, Iyo M
Neuropsychiatric Disease and Treatment 2015, 11:1845-1851
Published Date: 29 July 2015
Remission, response, and relapse rates in patients with acute schizophrenia treated with olanzapine monotherapy or other atypical antipsychotic monotherapy: 12-month prospective observational study
Takahashi M, Nakahara N, Fujikoshi S, Iyo M
Pragmatic and Observational Research 2015, 6:39-46
Published Date: 14 July 2015
Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions
Okamoto H, Iyo M, Ueda K, Han C, Hirasaki Y, Namiki T
Neuropsychiatric Disease and Treatment 2014, 10:1727-1742
Published Date: 12 September 2014
Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study
Sasaki T, Hashimoto K, Tachibana M, Kurata T, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M
Neuropsychiatric Disease and Treatment 2014, 10:719-722
Published Date: 5 May 2014
Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study
Sasaki T, Hashimoto K, Tachibana M, Kurata T, Okawada K, Ishikawa M, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M
Neuropsychiatric Disease and Treatment 2014, 10:147-151
Published Date: 24 January 2014
Orengedoku-to augmentation in cases showing partial response to yokukan-san treatment: a case report and literature review of the evidence for use of these Kampo herbal formulae
Okamoto H, Chino A, Hirasaki Y, Ueda K, Iyo M, Namiki T
Neuropsychiatric Disease and Treatment 2013, 9:151-155
Published Date: 18 January 2013